- This event has passed.
Brexit & the EEA QPPV – What Now?
January 18 @ 10:00 - 11:00 UTC+0
A Pharmacovigilance Webinar on Brexit & the EEA QPPV - What Now?
Miranda Dollen, BSc (Hons) -
Vice President. Pharmacovigilance, Mapi Group
A significant proportion of EEA QPPVs are located in the UK. Given that this role has a legal requirement for the appointee to be resident in the EEA, what is the impact of Brexit?
This session will discuss industry concerns about the loss of EEA QPPV expertise from the UK industry, the loss of impact of the MHRA’s influence on the role of the EEA QPPV, and other potential associated risks.
It will also discuss the industry’s role in escalating these concerns to key stakeholders during forthcoming Brexit negotiations and speculate if there is any opportunity in the changes ahead.
Webinar Registration (Limited Seats Available):
How to Acquire Technical Support for Mapi Webinar:
For registration and log-in assistance, contact Julia Callahan (Mapi's Marketing Assistant/Webinar Moderator) - Email [email protected]
For webinar presentation questions regarding what content will be discussed, contact our webinar host directly at [email protected]
Learn More about Mapi's Pharmacovigilance Services & Expertise:
Register for Additional Upcoming Pharmacovigilance Webinars:
View Archived Pharmacovigilance Webinar Recordings Now: